Reviews and feature articleWhat effect does asthma treatment have on airway remodeling? Current perspectives
Section snippets
What are the effects of corticosteroids on airway remodeling?
Corticosteroids, either inhaled (ICSs) or systemic (oral corticosteroids), modulate acute and chronic inflammation in asthmatic subjects, particularly in those with milder disease, and have broad pharmacologic actions.14, 15 Consequently, glucocorticoids are considered the therapeutic mainstay for chronic asthma and its underlying inflammation. Indeed, as a result of the “chronic inflammation leads to remodeling” paradigm, corticosteroids have long played a central role in interventional
What is the effect of combination treatment with ICS and long-acting β2-agonists on remodeling?
Burgess et al71 found that neither ICS nor long-acting β2-agonist (LABA) monotherapy inhibited TGF-β–stimulated release of ECM proteins and cytokines in an in vitro model. However, another recent in vitro study found that combination treatment with LABAs and ICSs versus monotherapy with either ICSs or LABAs was superior in regulating excessive matrix production in human fibroblast cultures.20 Wang et al72 demonstrated decreases in MMP-9, TIMP-1, and TGF-β levels in sputum samples and decreased
What is the effect of omalizumab on remodeling?
IgE contributes to the pathophysiology of allergic diseases by attaching to mast cells and regulating its mediator release. These mediators can then initiate a cascade of inflammation involving B and T lymphocytes, eosinophils, fibroblasts, ASM, and epithelial cells, which then results in the release of a multitude of cytokines and chemokines to intensify airway inflammation, symptoms, and possibly remodeling.75
Omalizumab is a recombinant humanized IgG1 mAb that binds to the Fc portion of free
What is the effect of mepolizumab (anti–IL-5) on remodeling?
Eosinophils play a role in airway remodeling in asthmatic subjects.30, 31 RBM thickening has been associated with increased numbers of eosinophils in the bronchial mucosa.30 Eosinophils also produce several mediators and cytokines (ie, TGF-β, VEGF, MMP-9, TIMP-1, and IL-13) that are capable of stimulating matrix remodeling.79 Interestingly, eosinophil-deficient mice are protected from peribronchiolar collagen deposition and increases in ASM; however, increases in AHR and mucus secretion still
What are the effects of anti–TNF-α on remodeling?
There is limited evidence that therapies against TNF-α are effective in subjects with severe asthma. However, in addition to promoting airway inflammation and AHR, TNF-α might play a central role in airway remodeling and induce glucocorticoid resistance, myocyte proliferation, vascular remodeling, and stimulation of fibroblast growth and maturation into myofibroblasts by promoting TGF-β expression.84, 85 Patients with treatment-refractory asthma have an upregulation of their TNF-α axis.86
What effects do leukotriene modifiers, anticholinergics, and tyrosine kinase inhibitors have on remodeling?
Although an extensive discussion of all treatments is beyond the scope of this article, to be more inclusive, it is helpful to briefly highlight the role of leukotriene modifiers, anticholinergics, and tyrosine kinase inhibitors in airway remodeling. Most of these observations lack human studies for confirmation.
Leukotriene modifiers suppress eosinophilic infiltration and eosinophil numbers in peripheral blood, sputum, and bronchoalveolar lavage fluid samples, as well as improving AHR and lung
Conclusions
Airway remodeling is a complex and incompletely defined process in asthmatic subjects that might contribute to pathophysiology, progression of airflow obstruction, and ultimately treatment responsiveness. Understanding which components of remodeling contribute to various physiologic consequences of asthma remains an important tenet of future pathophysiological, diagnostic, and therapeutic approaches. Additionally, there must be human studies to assess the effects of higher dosing and longer
References (99)
- et al.
Histopathology of severe childhood asthma: a case series
Chest
(2003) - et al.
Effect of extracellular matrix composition on airway epithelial cell and fibroblast structure: implications for airway remodeling in asthma
Ann Allergy Asthma Immunol
(2009) - et al.
Airway remodeling in asthma
Curr Opin Pharmacol
(2010) - et al.
Subepithelial fibrosis in the bronchi of asthmatics
Lancet
(1989) - et al.
Budesonide/formoterol effects on metalloproteolytic balance in TGFbeta-activated human lung fibroblasts
Respir Med
(2009) - et al.
Structural changes of the airway wall impair respiratory function, even in mild asthma
Chest
(2002) - et al.
Specificity of basement membrane thickening in severe asthma
J Allergy Clin Immunol
(2007) - et al.
Inhaled corticosteroids decrease subepithelial collagen deposition by modulation of the balance between matrix metalloproteinase-9 and tissue inhibitor of metalloproteinase-1 expression in asthma
J Allergy Clin Immunol
(1999) - et al.
Evidence of remodeling in peripheral airways of patients with mild to moderate asthma: effect of hydrofluoroalkane-flunisolide
J Allergy Clin Immunol
(2005) - et al.
Airway remodeling-associated mediators in moderate to severe asthma: effect of steroids on TGF-beta, IL-11, IL-17, and type I and type III collagen expression
J Allergy Clin Immunol
(2003)
Airway remodeling and persistent airway obstruction in asthma
J Allergy Clin Immunol
Differences in airway remodeling between subjects with severe and moderate asthma
J Allergy Clin Immunol
Effects of ciclesonide and fluticasone propionate on allergen-induced airway inflammation and remodeling features
J Allergy Clin Immunol
Airway remodeling in asthma
Allergol Int
Recent advances in the pathophysiology of asthma
Chest
Corticosteroid-induced apoptosis of airway epithelium: a potential mechanism for chronic airway epithelial damage in asthma
Chest
Marked goblet cell hyperplasia with mucus accumulation in the airways of patients who died of severe acute asthma attack
Chest
A phosphodiesterase 4 inhibitor inhibits matrix protein deposition in airways in vitro
J Allergy Clin Immunol
Efficacy and safety of subcutaneous omalizumab vs placebo as add-on therapy to corticosteroids for children and adults with asthma: a systematic review
Chest
Effects of omalizumab and budesonide on markers of inflammation in human bronchial epithelial cells
Ann Allergy Asthma Immunol
Anti-IgE: lessons learned from effects on airway inflammation and asthma exacerbation
J Allergy Clin Immunol
Reduction of eosinophilic inflammation in the airways of patients with asthma using montelukast
Chest
Effects of erlotinib on pulmonary function and airway remodeling after sensitization and repeated allergen challenge in Brown-Norway rats
Respir Physiol Neurobiol
Is airway remodeling clinically relevant in asthma?
Am J Med
Asthma therapy and airway remodeling
J Allergy Clin Immunol
Unsuspected pseudophysiologic emphysema in chronic persistent asthma
Am J Respir Crit Care Med
Airway remodeling in asthma: new insights
J Allergy Clin Immunol
Impact of inhaled corticosteroids and leukotriene receptor antagonists on airway remodeling
Clin Rev Allergy Immunol
Epithelial damage and angiogenesis in the airways of children with asthma
Am J Respir Crit Care Med
Nonatopic children with multitrigger wheezing have airway pathology comparable to atopic asthma
Am J Respir Crit Care Med
Early thickening of the reticular basement membrane in children with difficult asthma
Am J Respir Crit Care Med
Airway remodeling and inflammation in symptomatic infants with reversible airflow obstruction
Am J Respir Crit Care Med
Airway wall remodeling: friend or foe?
J Appl Physiol
Structural basis for exaggerated airway narrowing
Can J Physiol Pharmacol
Remodelling of airway smooth muscle in asthma: what sort do you have?
Clin Exp Allergy
Global strategy for asthma management and prevention: GINA executive summary
Eur Respir J
Expert Panel Report 3 (EPR-3): guidelines for the diagnosis and management of asthma—summary report 2007
J Allergy Clin Immunol
Severe exacerbations predict excess lung function decline in asthma
Eur Respir J
Severe exacerbations and decline in lung function in asthma
Am J Respir Crit Care Med
Increased matrix metalloproteinase-9 in the airway after allergen challenge
Am J Respir Crit Care Med
Immunologic and inflammatory mechanisms that drive asthma progression to remodeling
J Allergy Clin Immunol
Transforming growth factor beta 1 (TGF beta 1) gene expression by eosinophils in asthmatic airway inflammation
Am J Respir Cell Mol Biol
Correlation between the bronchial subepithelial layer and whole airway wall thickness in patients with asthma
Thorax
On the functional consequences of bronchial basement membrane thickening
J Appl Physiol
Reduced airway distensibility, fixed airflow limitation, and airway wall remodeling in asthma
Am J Respir Crit Care Med
Hypothesis: excessive bronchoconstriction in asthma is due to decreased airway elastance
Eur Respir J
Clinical control and histopathologic outcome of asthma when using airway hyperresponsiveness as an additional guide to long-term treatment. The AMPUL Study Group
Am J Respir Crit Care Med
Airway inflammation, basement membrane thickening and bronchial hyperresponsiveness in asthma
Thorax
Inhaled corticosteroids decrease vascularity of the bronchial mucosa in patients with asthma
Clin Exp Allergy
Cited by (149)
Inhaled drug delivery for the targeted treatment of asthma
2023, Advanced Drug Delivery ReviewsCurrent Limitations and Recent Advances in the Management of Asthma
2023, Disease-a-MonthAsthma and autoimmunity
2022, Translational Autoimmunity: Autoimmune Disease Associated with Different Clinical FeaturesSeafood nutraceuticals: Health benefits and functional properties
2021, Research and Technological Advances in Food SciencePathology of Asthma
2021, Encyclopedia of Respiratory Medicine, Second EditionRole of biomarkers and effect of FIP-fve in acute and chronic animal asthma models
2020, Journal of Microbiology, Immunology and Infection
Series editors: Donald Y. M. Leung, MD, PhD, and Dennis K. Ledford, MD